These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 7150340)

  • 21. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Treat Rep; 1985 May; 69(5):523-5. PubMed ID: 4005874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
    Tsuruo T; Matsuzaki T; Matsushita M; Saito H; Yokokura T
    Cancer Chemother Pharmacol; 1988; 21(1):71-4. PubMed ID: 3342468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
    Radel S; Mayhew E; Rustum YM
    Anticancer Res; 1987; 7(6):1105-8. PubMed ID: 3442407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
    Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
    Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.
    Naito M; Hamada H; Tsuruo T
    J Biol Chem; 1988 Aug; 263(24):11887-91. PubMed ID: 3165378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
    Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patterns.
    Tsuruo T; Kawabata H; Nagumo N; Iida H; Kitatani Y; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1985; 15(1):16-9. PubMed ID: 4006044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M; Maruyama E
    Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
    Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cytotoxicities of various morpholinyl anthracyclines.
    Streeter DG; Taylor DL; Acton EM; Peters JH
    Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
    Streeter DG; Johl JS; Gordon GR; Peters JH
    Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.
    Müller MR; Lennartz K; Boogen C; Nowrousian MR; Rajewsky MF; Seeber S
    Ann Hematol; 1992 Nov; 65(5):206-12. PubMed ID: 1360820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H; Inaba M; Tsuruo T
    Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D.
    Kurosawa K; Takahashi K; Tsuda E; Tomida A; Tsuruo T
    Jpn J Cancer Res; 2001 Nov; 92(11):1235-41. PubMed ID: 11714449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming of multidrug resistance by VA-033, a novel derivative of apovincaminic acid ester.
    Nanaumi K; Tsuchida K; Nakaike S; Yamagishi T; Ichihara T; Takahashi K; Watajima H; Suzuki Y; Naito M; Tsuruo T
    Eur J Pharmacol; 1997 May; 327(2-3):239-46. PubMed ID: 9200566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 May; 43(5):2267-72. PubMed ID: 6831450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.